During the past decade, Hospital Universitario de Jaen conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 7 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 4 clinical trials were completed. i.e. 11.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario de Jaen" #1 sponsor was "Fundación GECP" with 7 trials, followed by "PETHEMA Foundation" with 5 trials sponsored, "Spanish Lung Cancer Group" with 5 trials sponsored, "MedSIR" with 4 trials sponsored and "Spanish Oncology Genito-Urinary Group" with 4 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Jaen" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator, "Itreas" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "NSABP Foundation Inc" with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Jaen" are "Breast Cancer" (6 trials), "Lung Cancer" (3 trials), "Non Small Cell Lung Cancer" (3 trials), "Covid19" (2 trials) and "Deep Venous Thrombosis" (2 trials). Many other conditions were trialed in "Hospital Universitario de Jaen" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de Jaen" are "Drug" (45 trials), "Biological" (7 trials), "Procedure" (4 trials), "Other" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (6 trials), "Docetaxel" (4 trials), "Cisplatin" (3 trials), "Nivolumab" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de Jaen" are 56 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario de Jaen". undefined are not yet recruiting, 26 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Hospital Universitario de Jaen, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de Jaen, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".